Clinical Trial Update: XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes two first-line regimens for advanced colorectal cancer in a Phase 2 study: XELOX with bevacizumab and XELIRI with bevacizum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Camptosar (irinotecan)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Harbin Medical University | Conditions: Colorectal Neoplasms, Chemotherapy | Phase 2 | Status: UNKNOWN